SanBio (4592), Earnings Report: Operating Loss of 1,909 Million Yen

SanBio (4592) has released its financial results, reporting an operating loss of 1,909 million yen and an ordinary loss of 1,730 million yen. Net income attributable to owners of the parent recorded a loss of 1,791 million yen, with basic earnings per share (EPS) at -22.95 yen. Total comprehensive income stood at a loss of 1,933 million yen. From a financial perspective, operating cash flow registered at -2.14 billion yen, and free cash flow was -2.06 billion yen, reflecting ongoing upfront investments in R&D and business operations. Meanwhile, cash and cash equivalents stood at 12.68 billion yen, and the equity ratio is maintained at a high level of 84.0%. Interest-bearing debt is 11.3 billion yen and retained earnings are 6.2 billion yen, warranting continued monitoring regarding the company's financial foundation for future operations.